About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Treatment to Prevent Side Effect Associated With Transfusions of Red Blood Cells

by Dr. Trupti Shirole on November 8, 2016 at 11:15 PM
Font : A-A+

 New Treatment to Prevent Side Effect Associated With Transfusions of Red Blood Cells

Blood transfusions are one of the top five medical procedures performed by physicians worldwide. A new treatment may diminish a dangerous side effect associated with transfusions of red blood cells (RBCs) known as pulmonary hypertension, an elevated blood pressure in the lungs and heart that can lead to heart failure, suggests a new study.

The findings are published in the November issue of Anesthesiology. The treatment involves exposing RBCs that have been collected, processed and stored for transfusion to the gas, nitric oxide.

Advertisement


Warren M. Zapol, study lead author and director of the Anesthesia Center for Critical Care Research at Massachusetts General Hospital in Boston. "Transfusions can be a life-saving therapy to replace blood cells or blood products lost as a result of severe bleeding after trauma, accident or surgery. Most blood transfusions are not 'whole blood' transfusions, but rather transfusions of certain blood products, with red blood cells being the most common."

Because supplies of freshly stored RBCs are limited, the U.S. Food and Drug Administration allows transfusion of human RBCs that have been stored for up to 42 days. However, recent studies suggest that transfusion of RBCs that have been stored for more than 30 days may lead to pulmonary hypertension and reduced survival of transfused RBCs, which can cause the body's cells to not get enough oxygen. Each year, approximately 326,000 patients in the United States receive one or more RBC units that have been stored for more than 30 days.
Advertisement

In the study, RBCs taken from lambs were stored for 40 days and then exposed to nitric oxide - a type of gas often given to treat term infants with pulmonary hypertension. One set of lambs received the treated RBCs through transfusion, while another set received stored RBCs not exposed to nitric oxide.

Researchers found transfusing RBCs that had not been pretreated with nitric oxide nearly doubled the constriction of blood vessels in the lungs, compared to RBCs pretreated with the gas. From this, the authors concluded that pretreating stored RBCs with nitric oxide reduces the risk of pulmonary hypertension.

In addition, treatment with nitric oxide increased the survival of stored RBCs after transfusion. When the 40-day-old pretreated RBCs were transfused into lambs, 87% of the cells remained in circulation after one hour, compared with 75% of non-treated RBCs. After 24 hours, 78% of red cells treated with nitric oxide remained in circulation, compared with 73% of RBCs not treated with nitric oxide.

"Extended storage of RBCs makes them rigid and decreases their ability to change shape, which is necessary as they travel through small blood vessels," said Dr. Zapol. "We found that pretreatment with nitric oxide actually rejuvenates RBCs, making them more flexible so they can more easily travel through blood vessels. This can further reduce the risk of pulmonary hypertension."

Further studies with transfused human-stored RBCs are required to confirm the beneficial effects of nitric oxide exposure, the researchers wrote.

Source: Eurekalert
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Research News

 Blind People Feel Their Heartbeat Better Than Those With Sight
Brain plasticity following blindness leads to superior ability in sensing signals from the heart, which has implications for bodily awareness and emotional processing.
New Biomarkers Help Detect Alzheimer's Disease Early
A group of scientists were awarded £1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.
Bone Health and Dementia: Establishing a Link
Is there a connection between Osteoporosis and dementia? Yes, loss in bone density may be linked to an increased risk of dementia in older age.
Is Telomere Shortening a Sign of Cellular Aging?
Link between chromosome length and biological aging marker discovered. The finding helps explain why people with longer telomeres have a lower dementia risk.
Why Is Integrated Structural Biology Important for Cystic Fibrosis?
Integrated structural biology helps discover how the cystic fibrosis transmembrane conductance regulator (CFTR) works.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Treatment to Prevent Side Effect Associated With Transfusions of Red Blood Cells Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests